Engineered receptor-biased IL-2–drug immunoconjugates selectively expand Tregs and suppress effector cells for autoimmune therapy

Chinese General Practice Journal · Elsevier

Аннотация

Publication date: 17 November 2026 Source: Cell Reports Medicine, Volume 7, Issue 11 Author(s): Jing Li, Shanbo Yang, Yeshuang Yuan, Ningxin Li, Xinyue Wang, Zhaolin Wang, Xingxing Zhu, Liwen Hua, Mengfan Yu, Yiming Wang, Xindang Chu, Jin Hu, Wei Song, Dezhong Ji, Qiuchen He, Yunyun Fei, Sulong Xiao, Lihe Zhang, Demin Zhou, Bo Zhang

Читать у издателя →

Похожие статьи